Researchers have uncovered early molecular warning signs of inflammatory bowel disease, revealing the condition can begin before symptoms appear and continue silently even when patients appear well. The WEHI-led study found a hidden flaw that can damage intestinal cells and is present even in patients whose disease is well controlled.